Receptor de IL
Los receptores de interleucina (receptores IL) son un grupo de receptores que se unen a las interleucinas, una familia de citocinas que desempeñan roles esenciales en la regulación del sistema inmunológico, la inflamación y la hematopoyesis. La desregulación de la señalización de interleucinas está asociada con diversas enfermedades inflamatorias y autoinmunes, lo que convierte a los receptores IL en objetivos críticos para la intervención terapéutica. Se están explorando los antagonistas de los receptores IL para el tratamiento de afecciones como la artritis reumatoide, la psoriasis y las enfermedades inflamatorias intestinales. En CymitQuimica, ofrecemos una gama de moduladores de receptores IL de alta calidad para apoyar su investigación en señalización de citocinas, inmunología y terapia de enfermedades inflamatorias.
Se han encontrado 121 productos para "Receptor de IL".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
CNTO 607
CNTO 607 (Anti-IL-13 Antibody) is a humanized antibody targeting IL-13, useful for studying inflammation.Pureza:98% (SDS-PAGE); 98.3% (SEC-HPLC) - 98% (SDS-PAGE); 98.3% (SEC-HPLC)Forma y color:Transparent LiquidPeso molecular:145.11 kDaCanakinumab
CAS:Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).Pureza:98.8%Forma y color:Transparent LiquidPeso molecular:145.18 kDaMyD88-IN-1
CAS:MyD88-IN-1: Potent MyD88 inhibitor with anti-inflammatory effects, blocking NF-κB and TLR/IL-1 pathways; potential for cancer and inflammation treatment.Fórmula:C23H24N6O7SPureza:99.99%Forma y color:SoildPeso molecular:528.54Ref: TM-T77353
1mg50,00€5mg147,00€1mL*10mM (DMSO)161,00€10mg213,00€25mg354,00€50mg439,00€100mg625,00€500mg1.288,00€Anti-inflammatory agent 42
CAS:Anti-inflammatory agent 42 has anti-inflammatory activity and inhibits the expression of TNF-α and IL-6 in LPS-stimulated macrophages.Fórmula:C20H12N2OSPureza:99.47%Forma y color:Yellow SolidPeso molecular:328.39Daclizumab
CAS:Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.Pureza:SDS-PAGE:95% SEC-HPLC:99.99%Forma y color:Transparent LiquidPeso molecular:144.12 kDaDectrekumab
CAS:Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13.Pureza:96.5% (SDS-PAGE); 97.1% (SEC-HPLC) - 96.5% (SDS-PAGE); 97.1% (SEC-HPLC)Forma y color:LiquidPeso molecular:146.27 kDaGuselkumab
CAS:Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.Pureza:SDS-PAGE:95% SEC-HPLC:98.97%Forma y color:Transparent LiquidPeso molecular:144.8 kDaRYTVELA TFA
CAS:RYTVELA TFA is a variant interleukin-1 receptor inhibitor with anti-inflammatory activity for the prevention of preterm labor and fetal protection.Fórmula:C38H62N10O12Forma y color:SolidPeso molecular:850.96Efavaleukin alfa
CAS:Efavaleukin alfa (AMG592) is a human monoclonal antibody comprising the IGHG1 Fc fragment fused to interleukin-2 (IL-2).Forma y color:LiquidZiltivekimab
CAS:Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases.Pureza:97.2% (SDS-PAGE); 98.9% (SEC-HPLC) - 97.9% (SDS-PAGE); 97.3% (SEC-HPLC)Forma y color:Transparent LiquidPeso molecular:145.39 kDaClazakizumab
CAS:Clazakizumab serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the circulating IL-6 protein which plays a pivotal role in the orchestration of chronic inflammation and immune dysregulation during strictly monitored laboratory observation periods and molecular investigations to evaluate the pharmacological potential of targeted cytokine blockade in specialized preclinical research environments to facilitate the development of novel immunotherapies.Pureza:95%Forma y color:Transparent LiquidMacrophage-activating lipopeptide 2 TFA
Macrophage-activating lipopeptide 2 TFA (MALP-2 TFA) is a diacylglycerol lipopeptide and TLR-2/TLR-6 agonist activates immune cell responses macrophages,Fórmula:C99H167N19O30S·xC2HF3O2Pureza:97.56%Forma y color:SolidPeso molecular:2135.56 (free base)CNTO4088
CNTO4088 serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the interleukin-23 protein which plays a pivotal role in maintaining the chronic inflammatory state during strictly monitored laboratory observation periods and molecular biology investigations to evaluate the pharmacological efficacy of targeted cytokine modulation in specialized preclinical research environments to facilitate the study of adaptive immunity.Forma y color:Odour LiquidAnti-Mouse IL-4 Antibody (11B11)
Anti-Mouse IL-4 Antibody (11B11) is an inhibitory antibody targeting mouse IL-4, with the clone number 11B11.Pureza:99%Forma y color:LiquidPeso molecular:150 kDaAnakinra
CAS:Anakinra (Raleukin) is an antagonist of recombinant, nonglycosylated human IL-1R. It is the first biological agent to block the pro-inflammatory effects.Fórmula:C759H1186N208O232S10Pureza:95% - ≥95%Forma y color:SolidPeso molecular:17257.6Anti-Human IL-17A
CAS:Anti-Human IL-17A (Secukinumab H chain) is a human monoclonal antibody targeting IL-17A, offering high affinity and low immunogenicity for psoriasis.Pureza:98%Forma y color:LiquidPeso molecular:~150 kDaIL-17A antagonist 1
CAS:IL-17A antagonist 1 is an IL-17A antagonist for the study of interleukin-related inflammatory and immune diseases.Fórmula:C33H41FN6O4Pureza:99.46%Forma y color:SolidPeso molecular:604.71Esonarimod
CAS:Esonarimod (KE-298) is an antirheumatic drug.Fórmula:C14H16O4SPureza:97.44%Forma y color:SolidPeso molecular:280.34CP 424174
CAS:CP 424174 blocks IL-1β processing (IC50: 210 nM), halts mature IL-1β formation, limits NLRP3, and is effective orally in vivo.Fórmula:C22H29ClN2O4SPureza:>99.99%Forma y color:SolidPeso molecular:452.99YM-90709
CAS:YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.Fórmula:C22H21N3O2Pureza:99.94%Forma y color:Red SolidPeso molecular:359.42
